Rb Regulates Interactions between Hematopoietic Stem Cells and Their Bone Marrow Microenvironment

Cell

Volumn 129, Issue 6, 2007, Pages 1081-1095

  Walkley, Carl R ^a   Shea, Jeremy M ^a   Sims, Natalie A ^b   Purton, Louise E ^c   Orkin, Stuart H ^a,d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

STEMCELL

Indexed keywords

RETINOBLASTOMA PROTEIN;

ARTICLE; BONE MARROW; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; CELL MOTILITY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKOCYTOSIS; LIFESPAN; LYMPHOPOIESIS; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

MURINAE;

EID: 34250363611     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2007.03.055     Document Type: Article

References (78)

1. Adams G.B., and Scadden D.T. The hematopoietic stem cell in its place. Nat. Immunol. 7 (2006) 333-337
2. Adams G.B., Chabner K.T., Alley I.R., Olson D.P., Szczepiorkowski Z.M., Poznansky M.C., Kos C.H., Pollak M.R., Brown E.M., and Scadden D.T. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439 (2006) 599-603
3. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6 (2004) 17-32
4. Anderson A.R.A., Weaver A.M., Cummings P.T., and Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127 (2006) 905-915
5. Arai F., Hirao A., Ohmura M., Sato H., Matsuoka S., Takubo K., Ito K., Koh G.Y., and Suda T. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161
6. Araki T., Mohi M.G., Ismat F.A., Bronson R.T., Williams I.R., Kutok J.L., Yang W., Pao L.I., Gilliland D.G., Epstein J.A., and Neel B.G. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat. Med. 10 (2004) 849-857
7. Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 4 (2004) 540-550
8. Bradford G.B., Williams B., Rossi R., and Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp. Hematol. 25 (1997) 445-453
9. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., Martin R.P., Schipani E., Divieti P., Bringhurst F.R., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
10. Chan I.T., Kutok J.L., Williams I.R., Cohen S., Kelly L., Shigematsu H., Johnson L., Akashi K., Tuveson D.A., Jacks T., and Gilliland D.G. Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J. Clin. Invest. 113 (2004) 528-538
11. Cheng T., Rodrigues N., Shen H., Yang Y., Dombkowski D., Sykes M., and Scadden D.T. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287 (2000) 1804-1808
12. Chien W.M., Rabin S., Macias E., Miliani de Marval P.L., Garrison K., Orthel J., Rodriguez-Puebla M., and Fero M.L. Genetic mosaics reveal both cell-autonomous and cell-nonautonomous function of murine p27Kip1. Proc. Natl. Acad. Sci. USA 103 (2006) 4122-4127
13. Clark A.J., Doyle K.M., and Humbert P.O. Cell-intrinsic requirement for pRb in erythropoiesis. Blood 104 (2004) 1324-1326
14. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., and Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8 (1999) 265-277
15. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., and Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433 (2005) 760-764
16. Fuchs E., Tumbar T., and Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 116 (2004) 769-778
17. Ghiaur G., Lee A., Bailey J., Cancelas J.A., Zheng Y., and Williams D.A. Inhibition of RhoA GTPase activity enhances hematopoietic stem and progenitor cell proliferation and engraftment. Blood 108 (2006) 2087-2094
18. Gothot A., van der Loo J.C., Clapp D.W., and Srour E.F. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92 (1998) 2641-2649
19. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
20. Hideshima T., and Anderson K.C. Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nat. Rev. Cancer 2 (2002) 927-937
21. Hill R., Song Y., Cardiff R.D., and Van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123 (2005) 1001-1011
22. Hodgson G.S., and Bradley T.R. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell?. Nature 281 (1979) 381-382
23. Hu N., Gulley M.L., Kung J.T., and Lee E.Y. Retinoblastoma gene deficiency has mitogenic but not tumorigenic effects on erythropoiesis. Cancer Res. 57 (1997) 4123-4129
24. Iavarone A., King E.R., Dai X.M., Leone G., Stanley E.R., and Lasorella A. Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. Nature 432 (2004) 1040-1045
25. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431 (2004) 997-1002
26. Janzen V., Forkert R., Fleming H.E., Saito Y., Waring M.T., Dombkowski D.M., Cheng T., DePinho R.A., Sharpless N.E., and Scadden D.T. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443 (2006) 421-426
27. Kenner L., Hoebertz A., Beil T., Keon N., Karreth F., Eferl R., Scheuch H., Szremska A., Amling M., Schorpp-Kistner M., et al. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J. Cell Biol. 164 (2004) 613-623
28. Kollet O., Dar A., Shivtiel S., Kalinkovich A., Lapid K., Sztainberg Y., Tesio M., Samstein R.M., Goichberg P., Spiegel A., et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12 (2006) 657-664
29. Kramer A., Schultheis B., Bergmann J., Willer A., Hegenbart U., Ho A.D., Goldschmidt H., and Hehlmann R. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma. Leukemia 16 (2002) 1844-1851
30. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., Levine J.E., Wang J., Hahn W.C., Gilliland D.G., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442 (2006) 818-822
31. Krosl J., Beslu N., Mayotte N., Humphries R.K., and Sauvageau G. The competitive nature of HOXB4-transduced HSC is limited by PBX1: the generation of ultra-competitive stem cells retaining full differentiation potential. Immunity 18 (2003) 561-571
32. Kuhn R., Schwenk F., Aguet M., and Rajewsky K. Inducible gene targeting in mice. Science 269 (1995) 1427-1429
33. Kurose K., Gilley K., Matsumoto S., Watson P.H., Zhou X.P., and Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat. Genet. 32 (2002) 355-357
34. Le D.T., Kong N., Zhu Y., Lauchle J.O., Aiyigari A., Braun B.S., Wang E., Kogan S.C., Le Beau M.M., Parada L., and Shannon K.M. Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood 103 (2004) 4243-4250
35. Lerner C., and Harrison D.E. 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp. Hematol. 18 (1990) 114-118
36. Lessard J., and Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423 (2003) 255-260
37. Li C.L., and Johnson G.R. Stem cell factor enhances the survival but not the self-renewal of murine hematopoietic long-term repopulating cells. Blood 84 (1994) 408-414
38. Martin T.J., and Sims N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11 (2005) 76-81
39. Mitsiades C.S., Mitsiades N.S., Munshi N.C., Richardson P.G., and Anderson K.C. The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions. Eur. J. Cancer 42 (2006) 1564-1573
40. Moore K.A., and Lemischka I.R. Stem cells and their niches. Science 311 (2006) 1880-1885
41. Oguro H., Iwama A., Morita Y., Kamijo T., van Lohuizen M., and Nakauchi H. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. J. Exp. Med. 203 (2006) 2247-2253
42. Oh P., Li Y., Yu J., Durr E., Krasinska K.M., Carver L.A., Testa J.E., and Schnitzer J.E. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429 (2004) 629-635
43. Okada S., Nakauchi H., Nagayoshi K., Nishikawa S., Miura Y., and Suda T. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 80 (1992) 3044-3050
44. Osawa M., Hanada K., Hamada H., and Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273 (1996) 242-245
45. Park I.K., Qian D., Kiel M., Becker M.W., Pihalja M., Weissman I.L., Morrison S.J., and Clarke M.F. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423 (2003) 302-305
46. Passegue E., Wagner E.F., and Weissman I.L. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells. Cell 119 (2004) 431-443
47. Passegue E., Wagers A.J., Giuriato S., Anderson W.C., and Weissman I.L. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 202 (2005) 1599-1611
48. Purton L.E., Bernstein I.D., and Collins S.J. All-trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit+Sca-1(+)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors. Blood 94 (1999) 483-495
49. Purton L.E., Bernstein I.D., and Collins S.J. All-trans retinoic acid enhances the long-term repopulating activity of cultured hematopoietic stem cells. Blood 95 (2000) 470-477
50. Purton L.E., Dworkin S., Olsen G.H., Walkley C.R., Fabb S.A., Collins S.J., and Chambon P. RAR{gamma} is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J. Exp. Med. 203 (2006) 1283-1293
51. Rasheed N., Wang X., Niu Q.T., Yeh J., and Li B. Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis. Hum. Mol. Genet. 15 (2006) 1938-1948
52. Sage J., Miller A.L., Perez-Mancera P.A., Wysocki J.M., and Jacks T. Acute mutation of retinoblastoma is sufficient for cell cycle re-entry. Nature 424 (2003) 223-228
53. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4 (1978) 7-25
54. Sherr C.J., and Roberts J.M. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 18 (2004) 2699-2711
55. Spangrude G.J., Brooks D.M., and Tumas D.B. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 85 (1995) 1006-1016
56. Spike B.T., Dirlam A., Dibling B.C., Marvin J., Williams B.O., Jacks T., and Macleod K.F. The Rb tumor suppressor is required for stress erythropoiesis. EMBO J. 23 (2004) 4319-4329
57. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., and Kinzler K.W. Genes expressed in human tumor endothelium. Science 289 (2000) 1197-1202
58. Stead E., White J., Faast R., Conn S., Goldstone S., Rathjen J., Dhingra U., Rathjen P., Walker D., and Dalton S. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21 (2002) 8320-8333
59. Stepanova L., and Sorrentino B.P. A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress. Blood 106 (2005) 827-832
60. Stier S., Ko Y., Forkert R., Lutz C., Neuhaus T., Grunewald E., Cheng T., Dombkowski D., Calvi L.M., Rittling S.R., and Scadden D.T. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201 (2005) 1781-1791
61. Szilvassy S.J., Humphries R.K., Lansdorp P.M., Eaves A.C., and Eaves C.J. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc. Natl. Acad. Sci. USA 87 (1990) 8736-8740
62. Tajima F., Sato T., Laver J.H., and Ogawa M. CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor. Blood 96 (2000) 1989-1993
63. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126 (1981) 1614-1619
64. Till J., and McCulloch E. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14 (1961) 213-222
65. Varnum-Finney B., Purton L.E., Yu M., Brashem-Stein C., Flowers D., Staats S., Moore K.A., Le Roux I., Mann R., Gray G., et al. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 91 (1998) 4084-4091
66. Visnjic D., Kalajzic Z., Rowe D.W., Katavic V., Lorenzo J., and Aguila H.L. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103 (2004) 3258-3264
67. Walkley C.R., Olsen G.H., Dworkin S., Fabb S.A., Swann J., McArthur G.A., Westmoreland S.V., Chambon P., Scadden D.T., and Purton L.E. A microenvironment-induced myeloproliferative syndrome caused by Retinoic Acid Receptor γ deficiency. Cell 129 (2007) 1097-1110 this issue
68. Walkley C.R., and Orkin S.H. Rb is dispensable for self-renewal and multilineage differentiation of adult hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 103 (2006) 9057-9062
69. Walkley C.R., Fero M.L., Chien W.M., Purton L.E., and McArthur G.A. Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells. Nat. Cell Biol. 7 (2005) 172-178
70. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
71. Whyatt D., and Grosveld F. Cell-nonautonomous function of the retinoblastoma tumour suppressor protein: new interpretations of old phenotypes. EMBO Rep. 3 (2002) 130-135
72. Wildwater M., Campilho A., Perez-Perez J.M., Heidstra R., Blilou I., Korthout H., Chatterjee J., Mariconti L., Gruissem W., and Scheres B. The RETINOBLASTOMA-RELATED gene regulates stem cell maintenance in Arabidopsis roots. Cell 123 (2005) 1337-1349
73. Yang L., Bryder D., Adolfsson J., Nygren J., Mansson R., Sigvardsson M., and Jacobsen S.E. Identification of Lin-Sca1+kit+CD34+Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated recipients. Blood 105 (2005) 2717-2723
74. Yilmaz O.H., Valdez R., Theisen B.K., Guo W., Ferguson D.O., Wu H., and Morrison S.J. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441 (2006) 475-482
75. Yuan Y., Shen H., Franklin D.S., Scadden D.T., and Cheng T. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat. Cell Biol. 6 (2004) 436-442
76. Zhang C.C., Kaba M., Ge G., Xie K., Tong W., Hug C., and Lodish H.F. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat. Med. 12 (2006) 240-245
77. Zhang J., Niu C., Ye L., Huang H., He X., Tong W.G., Ross J., Haug J., Johnson T., Feng J.Q., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425 (2003) 836-841
78. Zhang J., Grindley J.C., Yin T., Jayasinghe S., He X.C., Ross J.T., Haug J.S., Rupp D., Porter-Westpfahl K.S., Wiedemann L.M., et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441 (2006) 518-522